BridgeMD
Compares treatment options for Incisional Hernia of Midline of Abdomen
Official title Open Vs. Endoscopic Transversus Abdominis Release Trial
ClinicalTrials.gov ID: NCT06195332
What this study is testing
- What it's testing
- This study aims to comparatively evaluate the early and long-term results of open and endoscopic TAR procedure for large midline incisional ventral hernias.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- midline incisional hernia
- defect width from 8 till 12 cm
- ASA I-III class
- able to give informed consent
- elective hernia repair
You likely can't join if
- primary ventral hernia
- lateral hernia with/without midline
- refuse to give informed consent
See the full eligibility criteria
- midline incisional hernia
- defect width from 8 till 12 cm
- ASA I-III class
- able to give informed consent
- elective hernia repair
- considered eligible for minimally invasive ventral hernia repair
- primary ventral hernia
- lateral hernia with/without midline
- refuse to give informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Moscow, Russia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Moscow, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.